Previous 10 | Next 10 |
2023-03-26 17:35:59 ET Major earnings expected after the bell on Monday include: Curaleaf Holdings ( OTCPK:CURLF ) PVH Corp. ( PVH ) WidePoint corporation ( WYY ) Hall of Fame Resort & Entertainment Company ( HOFV ) FreightCar America ( RAIL ) ...
2023-03-26 17:35:00 ET CytomX ( NASDAQ: CTMX ) is scheduled to announce Q4 earnings results on Monday, March 27th, after market close. The consensus EPS Estimate is -$0.24 (+81.5% Y/Y) and the consensus Revenue Estimate is $18.37M (-73.6% Y/Y). Over the last 1 year, CT...
2023-03-24 09:00:16 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2023 – USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs being labeled as ...
SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that it will report full year 2022 financial results on Monday, March 27, 2023, after the close of ...
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in the following inve...
Summary The COVID-19 public health emergency is coming to end in May 2023. As a result, Moderna, Inc. is approaching a long earnings trough after a couple years of mind-blowing growth. The market is going to hyper-fixate on the expected year-over-year declines in earnings in the upcomin...
CytomX Therapeutics ( NASDAQ: CTMX ) stock rose ~8% on Thursday after the company said it will get $5M in milestone payment from Astellas Pharma ( OTCPK:ALPMF ) ( OTCPK:ALPMY ) under their collaboration agreement. The companies achieved the first clinical candidate...
-Achievement of clinical candidate is the first in the multi-target collaboration and triggers a $5 million milestone payment to CytomX- -CytomX-retained US co-commercialization and economic rights for select programs- SOUTH SAN FRANCISCO, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE...
The following slide deck was published by CytomX Therapeutics, Inc. in conjunction with this event. For further details see: CytomX Therapeutics (CTMX) Presents at the 41st Annual J.P. Morgan Healthcare Conference - Slideshow
SOUTH SAN FRANCISCO, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will present at the B. Ril...
News, Short Squeeze, Breakout and More Instantly...
CytomX Therapeutics Inc. Company Name:
CTMX Stock Symbol:
NASDAQ Market:
CytomX Therapeutics Inc. Website:
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a firesid...
SOUTH SAN FRANCISCO, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced the promotion of Chris Ogden to Chief Financial Officer effective June 15, 2024. “Chris has mad...